200 related articles for article (PubMed ID: 21184030)
1. Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenografts.
Philipova T; Baryawno N; Hartmann W; Pietsch T; Druid H; Johnsen JI; Ekström TJ
Int J Oncol; 2011 Mar; 38(3):843-9. PubMed ID: 21184030
[TBL] [Abstract][Full Text] [Related]
2. Infrequent p53 gene mutations in medulloblastomas.
Saylors RL; Sidransky D; Friedman HS; Bigner SH; Bigner DD; Vogelstein B; Brodeur GM
Cancer Res; 1991 Sep; 51(17):4721-3. PubMed ID: 1873817
[TBL] [Abstract][Full Text] [Related]
3. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H
Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550
[TBL] [Abstract][Full Text] [Related]
4. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.
Traenka C; Remke M; Korshunov A; Bender S; Hielscher T; Northcott PA; Witt H; Ryzhova M; Felsberg J; Benner A; Riester S; Scheurlen W; Grunewald TG; von Deimling A; Kulozik AE; Reifenberger G; Taylor MD; Lichter P; Butt E; Pfister SM
Cancer Res; 2010 Oct; 70(20):8003-14. PubMed ID: 20924110
[TBL] [Abstract][Full Text] [Related]
5. High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma.
Inda MM; Muñoz J; Coullin P; Fauvet D; Danglot G; Tuñón T; Bernheim A; Castresana JS
Histopathology; 2006 Apr; 48(5):579-87. PubMed ID: 16623784
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma.
Krynska B; Del Valle L; Gordon J; Otte J; Croul S; Khalili K
Virology; 2000 Aug; 274(1):65-74. PubMed ID: 10936089
[TBL] [Abstract][Full Text] [Related]
8. A molecular fingerprint for medulloblastoma.
Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
[TBL] [Abstract][Full Text] [Related]
10. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines.
Bunt J; de Haas TG; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M
Mol Cancer Res; 2010 Oct; 8(10):1344-57. PubMed ID: 21047732
[TBL] [Abstract][Full Text] [Related]
13. Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts.
He XM; Wikstrand CJ; Friedman HS; Bigner SH; Pleasure S; Trojanowski JQ; Bigner DD
Lab Invest; 1991 Jun; 64(6):833-43. PubMed ID: 1904513
[TBL] [Abstract][Full Text] [Related]
14. c-myc overexpression causes anaplasia in medulloblastoma.
Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
16. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
[TBL] [Abstract][Full Text] [Related]
19. p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma.
Adesina AM; Nalbantoglu J; Cavenee WK
Cancer Res; 1994 Nov; 54(21):5649-51. PubMed ID: 7923211
[TBL] [Abstract][Full Text] [Related]
20. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.
Vaidyanathan G; Friedman HS; Affleck DJ; Schottelius M; Wester HJ; Zalutsky MR
Clin Cancer Res; 2003 May; 9(5):1868-76. PubMed ID: 12738745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]